Brief: Alligator Bioscience Q3 Oper Loss Widens To SEK 51.4 Mln
20/10/2022 07:15
Oct 20 (Reuters) - Alligator Bioscience AB ATORX.ST :
* Q3 NET SALES SEK 5.1 MILLION VERSUS SEK 3.3 MILLION YEAR
AGO
* Q3 OPERATING LOSS SEK 51.4 MILLION VERSUS LOSS SEK 37.7
MILLION
YEAR AGO
Source text for Eikon: ID:nMFN4kwDSw
Further company coverage: ATORX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Alligator Bioscience AB
See all newsBrief: Alligator Bioscience Q1 Net Loss SEK 1.4 Million
Sweden's Alligator Bioscience posts Q1 net profit, narrows operating loss
Brief: Alligator Bioscience Q1 EBIT SEK -17.8 Million
Brief: Alligator Bioscience Signs LoI With Unicancer For Phase 3 Mitazalimab Development
Brief: Exercise Of Warrants Brings Alligator Bioscience Net Proceeds Of SEK 12 Mln